-
17133-10A potent thrombin inhibitor (Ki = 4.5 nM) also inhibits trypsin (Ki = 50.3 nM), but only weakly inhibits other serine proteases has poor bioavailability after oral administration.
-
17133-5A potent thrombin inhibitor (Ki = 4.5 nM) also inhibits trypsin (Ki = 50.3 nM), but only weakly inhibits other serine proteases has poor bioavailability after oral administration.
-
17133-50A potent thrombin inhibitor (Ki = 4.5 nM) also inhibits trypsin (Ki = 50.3 nM), but only weakly inhibits other serine proteases has poor bioavailability after oral administration.
-
16989-10A selective inhibitor of mutant B-RafV600E (IC<sub>50</sub> = 0.8 nM), with 4- and 6-fold reduced potency against wild type B-Raf and c-Raf (IC<sub>50</sub>s = 3.
-
16989-25A selective inhibitor of mutant B-RafV600E (IC<sub>50</sub> = 0.8 nM), with 4- and 6-fold reduced potency against wild type B-Raf and c-Raf (IC<sub>50</sub>s = 3.
-
16989-5A selective inhibitor of mutant B-RafV600E (IC<sub>50</sub> = 0.8 nM), with 4- and 6-fold reduced potency against wild type B-Raf and c-Raf (IC<sub>50</sub>s = 3.
-
16989-50A selective inhibitor of mutant B-RafV600E (IC<sub>50</sub> = 0.8 nM), with 4- and 6-fold reduced potency against wild type B-Raf and c-Raf (IC<sub>50</sub>s = 3.
-
85165-1DAF-2 diacetate is a sensitive fluorescent indicator for the detection and bioimaging of NO. It is a cell-permeable derivative of DAF-2.
-
85165-100DAF-2 diacetate is a sensitive fluorescent indicator for the detection and bioimaging of NO. It is a cell-permeable derivative of DAF-2.
-
85165-250DAF-2 diacetate is a sensitive fluorescent indicator for the detection and bioimaging of NO. It is a cell-permeable derivative of DAF-2.
-
85165-500DAF-2 diacetate is a sensitive fluorescent indicator for the detection and bioimaging of NO. It is a cell-permeable derivative of DAF-2.
-
85160-1DAF-2 is a sensitive fluorescent indicator commonly used for the detection of NO. It reacts with NO in the presence of oxygen to yield the highly fluorescent triazolofluorescein (DAF-2T).